About the Journal

QES MedPharm Journal is an international, peer-reviewed scholarly journal dedicated to advancing research across the medical, pharmaceutical, biomedical and interdisciplinary health sciences. The journal provides a platform for researchers, clinicians, academicians and healthcare professionals to publish scientifically rigorous, ethically conducted and clinically relevant work.

The journal welcomes original research articles, systematic reviews, meta-analyses, narrative and scoping reviews, short communications, case reports, perspectives, commentaries and editorials. Its scope includes, but is not limited to, clinical medicine, pharmacology, toxicology, pharmaceutics, pharmaceutical sciences, drug discovery and development, natural products, molecular and cellular medicine, translational research, diagnostics, therapeutics, public health, biomedical sciences, computational medicine and emerging healthcare technologies.

QES MedPharm Journal is committed to rigorous peer review, editorial independence, research integrity, publication ethics and transparent scientific reporting. The journal aims to promote meaningful academic dialogue, interdisciplinary collaboration and the responsible dissemination of research that can contribute to improved healthcare, pharmaceutical innovation and evidence-based clinical practice.

The journal particularly encourages submissions that address emerging medical challenges, innovative therapeutic approaches, biomarkers, precision medicine, antimicrobial resistance, artificial intelligence in healthcare, experimental disease models, translational pharmacology and the integration of in silico, in vitro, in vivo and clinical research.

Through an inclusive and internationally oriented publishing platform, QES MedPharm Journal seeks to support both established and early-career researchers and to strengthen the communication of high-quality scientific evidence to the global research community.